Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shan Su
Observed names:
S Su,
S. Su,
Su, Shan
Institution:
Central Hospital of Zibo
Observed institutions:
Shandong University,
Guangdong General Hospital,
Shandong Provincial Hospital,
Guangdong Academy of Medical Sciences,
Central Hospital of Zibo,
Guangzhou Chest Hospital,
Southern Medical University
show all 7
ORCID:
0000-0001-7694-8699
Observed ORCID:
0000-0001-7694-8699
OpenAlex ID:
A5004597523
Strong Programmed Death Ligand 1 Expression Predicts Poor Response and De Novo Resistance to EGFR Tyrosine Kinase Inhibitors Among NSCLC Patients With EGFR Mutation
2018
·
Shan Su
, Zhong-Yi Dong
, et al.
·
Journal of Thoracic Oncology
·
151
Hyaluronic acid-modified selenium nanoparticles for enhancing the therapeutic efficacy of paclitaxel in lung cancer therapy
2019
·
Jianjun Zou
, Shan Su
, et al.
·
Artificial Cells Nanomedicine and Biotechnology
·
70
Bufalin inhibits ovarian carcinoma via targeting mTOR/HIF‐α pathway
2020
·
Shan Su
, Hongtao Dou
, et al.
·
Basic & Clinical Pharmacology & Toxicology
·
33
Efficacy and safety of concurrent anti-tuberculosis treatment and chemotherapy in lung cancer patients with co-existent tuberculosis
2020
·
Mei-Feng Ye
, Shan Su
, et al.
·
Annals of Translational Medicine
·
29
PDF
Expression of Steroidogenic Factor 1 (SF-1) and Steroidogenic Acute Regulatory Protein (StAR) in Endometriosis is Associated with Endometriosis Severity
2009
·
Y Tian
, B Kong
, et al.
·
Journal of International Medical Research
·
27
PDF
Clinical trials of tyrosine kinase inhibitors for lung cancer in China: a review
2017
·
Shan Su
, Yi-Long Wu
·
Journal of Hematology & Oncology
·
25
MiR-204 suppresses cell proliferation and promotes apoptosis in ovarian granulosa cells via targeting TPT1 in polycystic ovary syndrome
2019
·
Xueqin Sun
, Shan Su
, et al.
·
Biochemistry and Cell Biology
·
24
CCL20 Promotes Ovarian Cancer Chemotherapy Resistance by Regulating ABCB1 Expression
2019
·
Shan Su
, Xueqin Sun
, et al.
·
Cell Structure and Function
·
23
PDF
Lentivirus-mediated knockdown of Krüppel-like factor 9 inhibits the growth of ovarian cancer
2014
·
Qing-hua Zhang
, Hong-tao Dou
, et al.
·
Archives of Gynecology and Obstetrics
·
22
Emodin Enhances the Chemosensitivity of Endometrial Cancer by Inhibiting ROS-Mediated Cisplatin-resistance
2017
·
Ning Ding
, Hong Zhang
, et al.
·
Anti-Cancer Agents in Medicinal Chemistry
·
21
Triptolide Antagonized the Cisplatin Resistance in Human Ovarian Cancer Cell Line A2780/CP70 via hsa-mir-6751
2018
·
Ruijuan Wang
, Xiaoping Ma
, et al.
·
Future Medicinal Chemistry
·
17
Effects of PARP-1 inhibitor and ERK inhibitor on epithelial mesenchymal transitions of the ovarian cancer SKOV3 cells
2016
·
Shan Su
, Xueyan Lin
, et al.
·
Pharmacological Reports
·
16
Assessment of anti-PD-(L)1 for patients with coexisting malignant tumor and tuberculosis classified by active, latent, and obsolete stage
2021
·
Shan Su
, Mei-Feng Ye
, et al.
·
BMC Medicine
·
15
PDF
The Drug Combination of SB202190 and SP600125 Significantly Inhibit the Growth and Metastasis of Olaparib-resistant Ovarian Cancer Cell
2018
·
Xinyan Chen
, Yumei Chen
, et al.
·
Current Pharmaceutical Biotechnology
·
15
Tumor Mutational Burden and Genomic Alterations in Chinese Small Cell Lung Cancer Measured by Whole-Exome Sequencing
2019
·
Shan Su
, Jian-Jun Zou
, et al.
·
BioMed Research International
·
13
PDF
Super-enhancer MYCNOS-SE promotes chemoresistance in small cell lung cancer by recruiting transcription factors CTCF and KLF15
2024
·
Yuchun Niu
, Yichun Tang
, et al.
·
Oncogene
·
10
Construction of a Prognostic Immune Signature for Squamous-Cell Lung Cancer to Predict Survival
2020
·
Rui-Lian Chen
, Jing-Xu Zhou
, et al.
·
Frontiers in Immunology
·
10
PDF
Epigallocatechin gallate inhibits ovarian cancer cell growth and induces cell apoptosis via activation of FOXO3A
2023
·
Zhe Zhang
, Qinghua Zhang
, et al.
·
In Vitro Cellular & Developmental Biology - Animal
·
8
Effect of mesenchymal-epithelial transition amplification on immune microenvironment and efficacy of immune checkpoint inhibitors in patients with non-small cell lung cancer
2021
·
Shan Su
, Anqi Lin
, et al.
·
Annals of Translational Medicine
·
6
PDF
The Efficacy and Safety of Anlotinib Alone and in Combination with Other Drugs in Advanced Lung Cancer: A Retrospective Cohort Study
2022
·
Lei Li
, Hui Zhang
, et al.
·
Computational and Mathematical Methods in Medicine
·
5
PDF
MA15.01 Strong PD-L1 Expression Predicts Poor Response and de Novo Resistance to EGFR TKIs Among Non-Small Cell Lung Cancer Patients with EGFR Mutation
2018
·
S. Su
, Z. Dong
, et al.
·
Journal of Thoracic Oncology
·
3
PDF
Successful rescue of PD-1 inhibitor-induced TEN by vincristine combination therapy: a case report and literature review
2025
·
Hui-Yi Huang
, Jia-Qi Liu
, et al.
·
Frontiers in Oncology
·
2
PDF
Pulmonary sarcomatoid carcinoma coexisting with tuberculosis: a case report and literature review
2025
·
Zhi-Hao Huang
, Yu-Fei Zhu
, et al.
·
Frontiers in Oncology
·
2
S100A8/A9 in recurrent pregnancy loss: Pathogenic mechanisms and therapeutic potential
2026
·
Jia Liu
, Shan Su
, et al.
·
Journal of Reproductive Immunology
·
1
P14.12 MET Amplification and Immune Checkpoint Inhibitor Efficacy in NSCLC
2021
·
S. Su
, P. Luo
, et al.
·
Journal of Thoracic Oncology
·
1
PDF
Show more works
View as search
Works count:
34
Citation count:
549
H-index:
14
I10-index:
17
Year
Topic
Type